 | • レポートコード：MRC2Q12-18492 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、粘膜下リフティング注射液のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 粘膜下リフティング注射液のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 粘膜下リフティング注射液の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 粘膜下リフティング注射液のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの粘膜下リフティング注射液の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の粘膜下リフティング注射液の売上および2028年までの予測に焦点を当てています。 粘膜下リフティング注射液のグローバル主要企業には、Bio Space、FUJIFILM Medical Systems、GI Supply、Aries Pharmaceuticals、Boston Scientific、Ovesco Endoscopy AG、ERBE Elektromedizin GmbH、Olympus、Zeon Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 粘膜下リフティング注射液市場は、タイプとアプリケーションによって区分されます。世界の粘膜下リフティング注射液市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 フィブリノーゲン混合物、デキストロース 【アプリケーション別セグメント】 病院、外来手術センター、外科センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 粘膜下リフティング注射液製品概要 - タイプ別市場（フィブリノーゲン混合物、デキストロース） - アプリケーション別市場（病院、外来手術センター、外科センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の粘膜下リフティング注射液販売量予測2017-2028 - 世界の粘膜下リフティング注射液売上予測2017-2028 - 粘膜下リフティング注射液の地域別販売量 - 粘膜下リフティング注射液の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別粘膜下リフティング注射液販売量 - 主要メーカー別粘膜下リフティング注射液売上 - 主要メーカー別粘膜下リフティング注射液価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（フィブリノーゲン混合物、デキストロース） - 粘膜下リフティング注射液のタイプ別販売量 - 粘膜下リフティング注射液のタイプ別売上 - 粘膜下リフティング注射液のタイプ別価格 ・アプリケーション別市場規模（病院、外来手術センター、外科センター、その他） - 粘膜下リフティング注射液のアプリケーション別販売量 - 粘膜下リフティング注射液のアプリケーション別売上 - 粘膜下リフティング注射液のアプリケーション別価格 ・北米市場 - 北米の粘膜下リフティング注射液市場規模（タイプ別、アプリケーション別） - 主要国別の粘膜下リフティング注射液市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの粘膜下リフティング注射液市場規模（タイプ別、アプリケーション別） - 主要国別の粘膜下リフティング注射液市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の粘膜下リフティング注射液市場規模（タイプ別、アプリケーション別） - 主要国別の粘膜下リフティング注射液市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の粘膜下リフティング注射液市場規模（タイプ別、アプリケーション別） - 主要国別の粘膜下リフティング注射液市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの粘膜下リフティング注射液市場規模（タイプ別、アプリケーション別） - 主要国別の粘膜下リフティング注射液市場規模（トルコ、サウジアラビア） ・企業情報 Bio Space、FUJIFILM Medical Systems、GI Supply、Aries Pharmaceuticals、Boston Scientific、Ovesco Endoscopy AG、ERBE Elektromedizin GmbH、Olympus、Zeon Medical ・産業チェーン及び販売チャネル分析 - 粘膜下リフティング注射液の産業チェーン分析 - 粘膜下リフティング注射液の原材料 - 粘膜下リフティング注射液の生産プロセス - 粘膜下リフティング注射液の販売及びマーケティング - 粘膜下リフティング注射液の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 粘膜下リフティング注射液の産業動向 - 粘膜下リフティング注射液のマーケットドライバー - 粘膜下リフティング注射液の課題 - 粘膜下リフティング注射液の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Submucosal Lifting Injection Solution is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Submucosal Lifting Injection Solution is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Submucosal Lifting Injection Solution is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Submucosal Lifting Injection Solution include Bio Space, FUJIFILM Medical Systems, GI Supply, Aries Pharmaceuticals, Boston Scientific, Ovesco Endoscopy AG, ERBE Elektromedizin GmbH, Olympus and Zeon Medical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Submucosal Lifting Injection Solution manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Submucosal Lifting Injection Solution market. Further, it explains the major drivers and regional dynamics of the global Submucosal Lifting Injection Solution market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Bio Space
FUJIFILM Medical Systems
GI Supply
Aries Pharmaceuticals
Boston Scientific
Ovesco Endoscopy AG
ERBE Elektromedizin GmbH
Olympus
Zeon Medical
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Submucosal Lifting Injection Solution Segment by Type
Fibrinogen Mixture
Dextrose
Submucosal Lifting Injection Solution Segment by Application
Hospitals
Ambulatory Surgical Centers
Surgical Centers
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Submucosal Lifting Injection Solution market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Submucosal Lifting Injection Solution, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Submucosal Lifting Injection Solution, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Submucosal Lifting Injection Solution, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Submucosal Lifting Injection Solution sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Submucosal Lifting Injection Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Submucosal Lifting Injection Solution sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Bio Space, FUJIFILM Medical Systems, GI Supply, Aries Pharmaceuticals, Boston Scientific, Ovesco Endoscopy AG, ERBE Elektromedizin GmbH, Olympus and Zeon Medical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Submucosal Lifting Injection Solution in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Submucosal Lifting Injection Solution manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Submucosal Lifting Injection Solution sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Submucosal Lifting Injection Solution Product Introduction
1.2 Market by Type
1.2.1 Global Submucosal Lifting Injection Solution Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fibrinogen Mixture
1.2.3 Dextrose
1.3 Market by Application
1.3.1 Global Submucosal Lifting Injection Solution Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Submucosal Lifting Injection Solution Sales Estimates and Forecasts 2017-2028
2.2 Global Submucosal Lifting Injection Solution Revenue Estimates and Forecasts 2017-2028
2.3 Global Submucosal Lifting Injection Solution Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Submucosal Lifting Injection Solution Sales by Region
2.4.1 Global Submucosal Lifting Injection Solution Sales by Region (2017-2022)
2.4.2 Global Sales Submucosal Lifting Injection Solution by Region (2023-2028)
2.5 Global Submucosal Lifting Injection Solution Revenue by Region
2.5.1 Global Submucosal Lifting Injection Solution Revenue by Region (2017-2022)
2.5.2 Global Submucosal Lifting Injection Solution Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Submucosal Lifting Injection Solution Sales by Manufacturers
3.1.1 Global Top Submucosal Lifting Injection Solution Manufacturers by Sales (2017-2022)
3.1.2 Global Submucosal Lifting Injection Solution Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Submucosal Lifting Injection Solution in 2021
3.2 Global Submucosal Lifting Injection Solution Revenue by Manufacturers
3.2.1 Global Submucosal Lifting Injection Solution Revenue by Manufacturers (2017-2022)
3.2.2 Global Submucosal Lifting Injection Solution Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Submucosal Lifting Injection Solution Revenue in 2021
3.3 Global Submucosal Lifting Injection Solution Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Submucosal Lifting Injection Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Submucosal Lifting Injection Solution Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Submucosal Lifting Injection Solution Sales by Type
4.1.1 Global Submucosal Lifting Injection Solution Historical Sales by Type (2017-2022)
4.1.2 Global Submucosal Lifting Injection Solution Forecasted Sales by Type (2023-2028)
4.1.3 Global Submucosal Lifting Injection Solution Sales Market Share by Type (2017-2028)
4.2 Global Submucosal Lifting Injection Solution Revenue by Type
4.2.1 Global Submucosal Lifting Injection Solution Historical Revenue by Type (2017-2022)
4.2.2 Global Submucosal Lifting Injection Solution Forecasted Revenue by Type (2023-2028)
4.2.3 Global Submucosal Lifting Injection Solution Revenue Market Share by Type (2017-2028)
4.3 Global Submucosal Lifting Injection Solution Price by Type
4.3.1 Global Submucosal Lifting Injection Solution Price by Type (2017-2022)
4.3.2 Global Submucosal Lifting Injection Solution Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Submucosal Lifting Injection Solution Sales by Application
5.1.1 Global Submucosal Lifting Injection Solution Historical Sales by Application (2017-2022)
5.1.2 Global Submucosal Lifting Injection Solution Forecasted Sales by Application (2023-2028)
5.1.3 Global Submucosal Lifting Injection Solution Sales Market Share by Application (2017-2028)
5.2 Global Submucosal Lifting Injection Solution Revenue by Application
5.2.1 Global Submucosal Lifting Injection Solution Historical Revenue by Application (2017-2022)
5.2.2 Global Submucosal Lifting Injection Solution Forecasted Revenue by Application (2023-2028)
5.2.3 Global Submucosal Lifting Injection Solution Revenue Market Share by Application (2017-2028)
5.3 Global Submucosal Lifting Injection Solution Price by Application
5.3.1 Global Submucosal Lifting Injection Solution Price by Application (2017-2022)
5.3.2 Global Submucosal Lifting Injection Solution Price Forecast by Application (2023-2028)
6 North America
6.1 North America Submucosal Lifting Injection Solution Market Size by Type
6.1.1 North America Submucosal Lifting Injection Solution Sales by Type (2017-2028)
6.1.2 North America Submucosal Lifting Injection Solution Revenue by Type (2017-2028)
6.2 North America Submucosal Lifting Injection Solution Market Size by Application
6.2.1 North America Submucosal Lifting Injection Solution Sales by Application (2017-2028)
6.2.2 North America Submucosal Lifting Injection Solution Revenue by Application (2017-2028)
6.3 North America Submucosal Lifting Injection Solution Market Size by Country
6.3.1 North America Submucosal Lifting Injection Solution Sales by Country (2017-2028)
6.3.2 North America Submucosal Lifting Injection Solution Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Submucosal Lifting Injection Solution Market Size by Type
7.1.1 Europe Submucosal Lifting Injection Solution Sales by Type (2017-2028)
7.1.2 Europe Submucosal Lifting Injection Solution Revenue by Type (2017-2028)
7.2 Europe Submucosal Lifting Injection Solution Market Size by Application
7.2.1 Europe Submucosal Lifting Injection Solution Sales by Application (2017-2028)
7.2.2 Europe Submucosal Lifting Injection Solution Revenue by Application (2017-2028)
7.3 Europe Submucosal Lifting Injection Solution Market Size by Country
7.3.1 Europe Submucosal Lifting Injection Solution Sales by Country (2017-2028)
7.3.2 Europe Submucosal Lifting Injection Solution Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Submucosal Lifting Injection Solution Market Size by Type
8.1.1 Asia Pacific Submucosal Lifting Injection Solution Sales by Type (2017-2028)
8.1.2 Asia Pacific Submucosal Lifting Injection Solution Revenue by Type (2017-2028)
8.2 Asia Pacific Submucosal Lifting Injection Solution Market Size by Application
8.2.1 Asia Pacific Submucosal Lifting Injection Solution Sales by Application (2017-2028)
8.2.2 Asia Pacific Submucosal Lifting Injection Solution Revenue by Application (2017-2028)
8.3 Asia Pacific Submucosal Lifting Injection Solution Market Size by Region
8.3.1 Asia Pacific Submucosal Lifting Injection Solution Sales by Region (2017-2028)
8.3.2 Asia Pacific Submucosal Lifting Injection Solution Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Submucosal Lifting Injection Solution Market Size by Type
9.1.1 Latin America Submucosal Lifting Injection Solution Sales by Type (2017-2028)
9.1.2 Latin America Submucosal Lifting Injection Solution Revenue by Type (2017-2028)
9.2 Latin America Submucosal Lifting Injection Solution Market Size by Application
9.2.1 Latin America Submucosal Lifting Injection Solution Sales by Application (2017-2028)
9.2.2 Latin America Submucosal Lifting Injection Solution Revenue by Application (2017-2028)
9.3 Latin America Submucosal Lifting Injection Solution Market Size by Country
9.3.1 Latin America Submucosal Lifting Injection Solution Sales by Country (2017-2028)
9.3.2 Latin America Submucosal Lifting Injection Solution Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Submucosal Lifting Injection Solution Market Size by Type
10.1.1 Middle East and Africa Submucosal Lifting Injection Solution Sales by Type (2017-2028)
10.1.2 Middle East and Africa Submucosal Lifting Injection Solution Revenue by Type (2017-2028)
10.2 Middle East and Africa Submucosal Lifting Injection Solution Market Size by Application
10.2.1 Middle East and Africa Submucosal Lifting Injection Solution Sales by Application (2017-2028)
10.2.2 Middle East and Africa Submucosal Lifting Injection Solution Revenue by Application (2017-2028)
10.3 Middle East and Africa Submucosal Lifting Injection Solution Market Size by Country
10.3.1 Middle East and Africa Submucosal Lifting Injection Solution Sales by Country (2017-2028)
10.3.2 Middle East and Africa Submucosal Lifting Injection Solution Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bio Space
11.1.1 Bio Space Corporation Information
11.1.2 Bio Space Overview
11.1.3 Bio Space Submucosal Lifting Injection Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bio Space Submucosal Lifting Injection Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bio Space Recent Developments
11.2 FUJIFILM Medical Systems
11.2.1 FUJIFILM Medical Systems Corporation Information
11.2.2 FUJIFILM Medical Systems Overview
11.2.3 FUJIFILM Medical Systems Submucosal Lifting Injection Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 FUJIFILM Medical Systems Submucosal Lifting Injection Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 FUJIFILM Medical Systems Recent Developments
11.3 GI Supply
11.3.1 GI Supply Corporation Information
11.3.2 GI Supply Overview
11.3.3 GI Supply Submucosal Lifting Injection Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 GI Supply Submucosal Lifting Injection Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GI Supply Recent Developments
11.4 Aries Pharmaceuticals
11.4.1 Aries Pharmaceuticals Corporation Information
11.4.2 Aries Pharmaceuticals Overview
11.4.3 Aries Pharmaceuticals Submucosal Lifting Injection Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Aries Pharmaceuticals Submucosal Lifting Injection Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Aries Pharmaceuticals Recent Developments
11.5 Boston Scientific
11.5.1 Boston Scientific Corporation Information
11.5.2 Boston Scientific Overview
11.5.3 Boston Scientific Submucosal Lifting Injection Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Boston Scientific Submucosal Lifting Injection Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Boston Scientific Recent Developments
11.6 Ovesco Endoscopy AG
11.6.1 Ovesco Endoscopy AG Corporation Information
11.6.2 Ovesco Endoscopy AG Overview
11.6.3 Ovesco Endoscopy AG Submucosal Lifting Injection Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Ovesco Endoscopy AG Submucosal Lifting Injection Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Ovesco Endoscopy AG Recent Developments
11.7 ERBE Elektromedizin GmbH
11.7.1 ERBE Elektromedizin GmbH Corporation Information
11.7.2 ERBE Elektromedizin GmbH Overview
11.7.3 ERBE Elektromedizin GmbH Submucosal Lifting Injection Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ERBE Elektromedizin GmbH Submucosal Lifting Injection Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ERBE Elektromedizin GmbH Recent Developments
11.8 Olympus
11.8.1 Olympus Corporation Information
11.8.2 Olympus Overview
11.8.3 Olympus Submucosal Lifting Injection Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Olympus Submucosal Lifting Injection Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Olympus Recent Developments
11.9 Zeon Medical
11.9.1 Zeon Medical Corporation Information
11.9.2 Zeon Medical Overview
11.9.3 Zeon Medical Submucosal Lifting Injection Solution Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Zeon Medical Submucosal Lifting Injection Solution Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Zeon Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Submucosal Lifting Injection Solution Industry Chain Analysis
12.2 Submucosal Lifting Injection Solution Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Submucosal Lifting Injection Solution Production Mode & Process
12.4 Submucosal Lifting Injection Solution Sales and Marketing
12.4.1 Submucosal Lifting Injection Solution Sales Channels
12.4.2 Submucosal Lifting Injection Solution Distributors
12.5 Submucosal Lifting Injection Solution Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Submucosal Lifting Injection Solution Industry Trends
13.2 Submucosal Lifting Injection Solution Market Drivers
13.3 Submucosal Lifting Injection Solution Market Challenges
13.4 Submucosal Lifting Injection Solution Market Restraints
14 Key Findings in The Global Submucosal Lifting Injection Solution Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer